|
Are you ready to place your study?
Fill out the form, and we'll contact you.
|
Quality - SOPs, adherence to GCP/ICH. We have experienced two routine FDA audits with positive results. (no 483's and favorable
auditor comments)
State of the art Equipment- utilizing the latest technology.
Personal Interaction - with the principal investigators and the management team to ensure scientific integrity and seamless execution.
Central IRB - which facilitates timely review.
|
Our investigators are renowned professionals. One of our
principal investigators is Dr. Neil Singla, chief executive officer of Lotus, who is an expert on protocol design and implementation.
With extensive experience and expertise, Dr. Sonia
Singla, the chief operating officer for Lotus, has served as the principal investigator for over 50 studies in this field.
view bios
|